European Vaccine Markets
Price (Single User PDF): $2,995.00
Price (Global Site License): $5,990.00
The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and willingness to pay for new products. This has encouraged market participants to increase spending in research and development.
This report, European Vaccine Markets, examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attack, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these conditions are discussed in Kalorama’s new report, “Emerging Vaccines: The World Market.”
The report includes vaccine market stats for:
The report also contains adult and pediatric vaccine regional market shares for the following countries:
*In this Kalorama Information Report "Rest of Europe" is broken down in the total market summary (adult and pediatric combined) to include regional market share of the total European Vaccine market for Benelux, Scandinavia, Switzerland, Russia, Poland, Balkans, Baltic Countries, Hungary and Other
The report also includes company market shares for European adult and pediatric vaccine markets, key issues and trend affecting the industry, and detailed profiles of major vaccine competitors, including:
Price (Global Site License): $5,990.00
The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and willingness to pay for new products. This has encouraged market participants to increase spending in research and development.
This report, European Vaccine Markets, examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attack, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these conditions are discussed in Kalorama’s new report, “Emerging Vaccines: The World Market.”
The report includes vaccine market stats for:
- Adult Vaccines-Estimates and Forecasts for
- Influenza
- Pneumococcal
- Meningitis/Pneumonia
- DTaP
- Hepatitis
- HPV
- Travel and Endemic
- Others
- Pediatric Vaccines-Estimates and Forecasts for:
- Haemophilus influenzae type b (Hib)
- Pneumococcal infection
- Diphtheria
- Tetanus
- Pertussis (whooping cough)
- Hepatitis A and B
- Rotavirus
- Polio
- Measles
- Mumps and Rubella
- Varicella (chicken pox)
- Influenza
- Meningitis
- Human papillomavirus (HPV)
- Combination Vaccines
- Others
The report also contains adult and pediatric vaccine regional market shares for the following countries:
- United Kingdom
- Germany
- Spain
- France
- Italy
- Rest of Europe*
*In this Kalorama Information Report "Rest of Europe" is broken down in the total market summary (adult and pediatric combined) to include regional market share of the total European Vaccine market for Benelux, Scandinavia, Switzerland, Russia, Poland, Balkans, Baltic Countries, Hungary and Other
The report also includes company market shares for European adult and pediatric vaccine markets, key issues and trend affecting the industry, and detailed profiles of major vaccine competitors, including:
- Bavarian Nordic A/S
- Baxter International
- Crucell
- Emergent Biosolutions
- GlaxoSmithKline
- Novartis
- Pfizer Inc.
- Sanofi Pasteur
CHAPTER ONE: EXECUTIVE SUMMARY
THE EUROPEAN VACCINES MARKET
Scope and Methodology
Overview
Pediatric Preventative Vaccines
Adult Preventative Vaccines
Total Market
Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Subunit Vaccines
Conjugate Vaccines
DNA Vaccination
Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Introduction
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Diphtheria
Pertussis
Tetanus
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Measles
Mumps
Rubella
Meningococcal Disease
Pneumococcal Conjugate
Rotavirus
Varicella
Pediatric Vaccines in Development
The European Market for Pediatric Preventive Vaccines
Total European Market Size and Forecast
European Market by Product Type
Haemophilus Influenzae Type B (Hib)
Pneumococcal
DTaP
Hepatitis A & B
Rotavirus
Polio
MMR
Varicella
Influenza
Menigococcal
HPV
Combinations
Others
Major Manufacturer’s Market Share—Pediatric Vaccines
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Recommendations for Adult Immunization
WHO International Health Regulations
Adult Vaccine Products
BCG
Cervical Cancer
Cholera
Diphtheria-Tetanus
Hepatitis
Hepatitis A
Hepatitis B
Influenza
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Adult Vaccines in Development
The European Market for Adult Preventive Vaccines
Total European Market Size and Forecast
European Market by Product Type
Influenza
DTaP Booster
HPV
Hepatitis
Meningitis/Pneumonia
Travel/Endemic Vaccines
Others
Major Manufacturer’s Market Share—Adult Vaccines
CHAPTER FIVE: VACCINES MARKET SUMMARY
Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors
CHAPTER SIX: ISSUES AND TRENDS
Vaccine Safety
Refusal to Immunize
Obesity
World Health Organization
The Future of Vaccine Safety
Vaccine Shortages
Financial incentives
Equitable pricing
Vaccine stockpiles
Smallpox
Tularemia
Viral Hemorrhagic Fevers
DNA Vaccination
Innovations in Vaccine Delivery Systems
Edible Vaccines
Mucosal Delivery
Intranasal Delivery
Vaccine Patches
Vaccine Chips
Innovations in Vaccine Production
Tobacco Plant
Insects
Nanoparticle Systems
CHAPTER SEVEN: COMPANY PROFILES
Bavarian Nordic A/S
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Baxter International
History and Lines of Business
Vaccine Products
Financial Information
Crucell
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Emergent Biosolutions
History and Lines of Business
Strategic Acquisition and Alliance
Vaccine Products
Financial
GlaxoSmithKline
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Novartis
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Pfizer Inc.
History and Lines of Business
Strategic alliances
Vaccine Products
Financial Information
Sanofi Pasteur
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
COMPANY DIRECTORY
THE EUROPEAN VACCINES MARKET
Scope and Methodology
Overview
Pediatric Preventative Vaccines
Adult Preventative Vaccines
Total Market
Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Subunit Vaccines
Conjugate Vaccines
DNA Vaccination
Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Introduction
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Diphtheria
Pertussis
Tetanus
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Measles
Mumps
Rubella
Meningococcal Disease
Pneumococcal Conjugate
Rotavirus
Varicella
Pediatric Vaccines in Development
The European Market for Pediatric Preventive Vaccines
Total European Market Size and Forecast
European Market by Product Type
Haemophilus Influenzae Type B (Hib)
Pneumococcal
DTaP
Hepatitis A & B
Rotavirus
Polio
MMR
Varicella
Influenza
Menigococcal
HPV
Combinations
Others
Major Manufacturer’s Market Share—Pediatric Vaccines
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Recommendations for Adult Immunization
WHO International Health Regulations
Adult Vaccine Products
BCG
Cervical Cancer
Cholera
Diphtheria-Tetanus
Hepatitis
Hepatitis A
Hepatitis B
Influenza
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Adult Vaccines in Development
The European Market for Adult Preventive Vaccines
Total European Market Size and Forecast
European Market by Product Type
Influenza
DTaP Booster
HPV
Hepatitis
Meningitis/Pneumonia
Travel/Endemic Vaccines
Others
Major Manufacturer’s Market Share—Adult Vaccines
CHAPTER FIVE: VACCINES MARKET SUMMARY
Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors
CHAPTER SIX: ISSUES AND TRENDS
Vaccine Safety
Refusal to Immunize
Obesity
World Health Organization
The Future of Vaccine Safety
Vaccine Shortages
Financial incentives
Equitable pricing
Vaccine stockpiles
Smallpox
Tularemia
Viral Hemorrhagic Fevers
DNA Vaccination
Innovations in Vaccine Delivery Systems
Edible Vaccines
Mucosal Delivery
Intranasal Delivery
Vaccine Patches
Vaccine Chips
Innovations in Vaccine Production
Tobacco Plant
Insects
Nanoparticle Systems
CHAPTER SEVEN: COMPANY PROFILES
Bavarian Nordic A/S
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Baxter International
History and Lines of Business
Vaccine Products
Financial Information
Crucell
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Emergent Biosolutions
History and Lines of Business
Strategic Acquisition and Alliance
Vaccine Products
Financial
GlaxoSmithKline
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Novartis
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Pfizer Inc.
History and Lines of Business
Strategic alliances
Vaccine Products
Financial Information
Sanofi Pasteur
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
COMPANY DIRECTORY
